2025 年 05 月 08 日 营收稳健增长，坚定大单品战略 买入(维持) 事件 | 分析师：孙山山 | S1050521110005 | | --- | --- | | sunss@cfsc.com.cn | | | 联系人：张倩 | S1050124070037 | | zhangqian@cfsc.com.cn | | | 基本数据 | 2025-05-08 | | --- | --- | | 当前股价（元） | 29.96 | | 总市值（亿元） | 44 | | 总股本（百万股） | 146 | | 流通股本（百万股） | 124 | | 52 周价格范围（元） | 22-47.98 | | 日均成交额（百万元） | 58.66 | 市场表现 -40 -30 -20 -10 0 10 20 30 (%) 仲景食品 沪深300 资料来源：Wind，华鑫证券研究 相关研究 1、《仲景食品（300908）：主力单 品稳健增长，电商渠道持续发力》 2025-03-28 2、《仲景食品（300908）：营收稳 健增长，电商渠道持续发力》2024- 10-18 3、《仲景食品（300908）：葱油延 续增长， ...

Core Insights - The company reported a slight increase in revenue of 1.06% year-on-year, reaching 277 million yuan in Q1 2025, but experienced a decline in net profit attributable to shareholders by 4.81%, indicating a phase of "increased revenue without increased profit" [1] Financial Performance - Operating costs decreased by 1.50% to 150 million yuan, attributed to adjustments in raw material procurement strategies and improved production efficiency [2] - Gross margin improved by 1.41 percentage points to 45.91%, supported by strategic procurement alliances and optimized inventory management [2] - Sales expenses rose by 11.96% to 51 million yuan, with the expense ratio increasing to 18.59%, primarily for offline channel expansion and brand promotion [2] - R&D expenses saw a significant increase of 27.64% to 10 million yuan, while financial expenses dropped by 53.29% due to reduced interest income, further impacting net profit margins [2] Strategic Developments - The company made a significant move in its business transformation with the launch of its first ready-to-eat health product, "Zhongjing Yuanqi Ginseng," which targets the convenient health food market [3] - The product is positioned within the concept of food and medicine integration, but faces challenges due to intense competition in the health food sector and the time required for consumer brand recognition [3] - The Nanyang Zhongjing Food Industrial Park's first phase, including the seasoning sauce workshop, has entered trial production, leveraging regional raw material advantages to reduce costs [3] Conclusion - The Q1 2025 performance reflects typical challenges faced by traditional food companies during consumption upgrade cycles, balancing short-term cost pressures and strategic transformation for long-term growth [4] - While improvements in gross margin and cash flow indicate effective internal management, the decline in net profit highlights mismatches between expense control and revenue growth [4] - The company's attempts in the health sector and industrial park development demonstrate strategic foresight, but the long nurturing period for new businesses and capacity digestion pressures remain significant challenges [4]

Core Viewpoint - The company reported a slight increase in revenue for Q1 2025, but a decline in net profit, indicating mixed performance amidst rising costs and increased expenses [1][2]. Financial Performance - Q1 2025 revenue reached 280 million, a year-on-year increase of 1.1%, reversing the previous quarter's decline of 0.4% [1]. - The gross margin improved both year-on-year by 1.4 percentage points to 45.9% and quarter-on-quarter by 7.5 percentage points [1]. - The net profit attributable to shareholders was 48 million, a year-on-year decrease of 4.8%, while the non-recurring net profit was 47 million, down 5.0% year-on-year [1]. - The company's net profit margin and non-recurring net profit margin both decreased by 1.1 percentage points to 17.5% and 17.1%, respectively [1]. Outlook for 2025 - The company plans to focus on promoting new products such as garlic sauce and zero-fat spicy sauce, with an emphasis on e-commerce channels and existing pharmacy systems [2]. - The company aims to deepen market penetration in the regions of its 61 sales offices and enhance the offline customer experience to boost sales [2]. - Despite rising raw material costs, the company anticipates an overall improvement in gross margin for 2025 compared to 2024, driven by price adjustments and a slight increase in mushroom prices [2]. - Revenue projections for 2025-2027 are 1.14 billion, 1.23 billion, and 1.32 billion, reflecting year-on-year growth rates of 4.0%, 7.6%, and 7.7%, respectively [2]. - Expected net profits for the same period are 190 million, 210 million, and 230 million, with year-on-year growth rates of 9.7%, 7.4%, and 9.4% [2].